Evaluation of flibanserin safety: Comparison with other serotonergic medications

Evaluation of flibanserin safety: Comparison with other serotonergic medicationsIntroduction: Flibanserin, a multifunctional serotonin agonist and antagonist, is approved by the U.S. Food and Drug Administration (FDA) for treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women. During the FDA’s review of flibanserin, concerns were raised about the risks of hypotension, syncope, and sedation-related…